Literature DB >> 21821558

The urgency of providing comprehensive and integrated treatment for substance abusers with HIV.

Nora D Volkow1, Julio Montaner.   

Abstract

Substance abuse is linked to many new cases of HIV infection. Barriers such as the myth that drug users cannot adhere to HIV/AIDS treatment block progress in curbing the spread of HIV in that population. In this article we explain the need to aggressively seek out high-risk, hard-to-reach substance abusers and to offer them HIV testing, access to treatment, and the necessary support to remain in treatment--both for HIV and for substance abuse. We summarize evidence showing that injection drug users can successfully undergo HIV treatment; that many substance abusers adhere to antiretroviral therapy as well as do people who don't inject drugs; and that injection drug users who undergo substance abuse treatment are more likely to obtain and stay in treatment for their HIV infection. This evidence makes a strong case for integrating substance abuse treatment with HIV treatment programs and providing substance abusers with universal access to HIV treatment. But an integrated strategy will require changes in the health care system to overcome lingering obstacles that inhibit the merging of substance abuse treatment with HIV programs.

Entities:  

Mesh:

Year:  2011        PMID: 21821558      PMCID: PMC3190599          DOI: 10.1377/hlthaff.2011.0663

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  62 in total

Review 1.  Structural interventions to reduce HIV transmission among injecting drug users.

Authors:  D C Des Jarlais
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

2.  Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.

Authors:  Sasha Uhlmann; M-J Milloy; Thomas Kerr; Ruth Zhang; Silvia Guillemi; David Marsh; Robert S Hogg; Julio S G Montaner; Evan Wood
Journal:  Addiction       Date:  2010-03-10       Impact factor: 6.526

3.  Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas.

Authors:  Samuel R Friedman; Hannah Lf Cooper; Barbara Tempalski; Maria Keem; Risa Friedman; Peter L Flom; Don C Des Jarlais
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

4.  Enhanced HIV testing, treatment, and support for HIV-infected substance users.

Authors:  Nora D Volkow; Julio Montaner
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

5.  HIV rapid testing in substance abuse treatment: implementation following a clinical trial.

Authors:  L F Haynes; J E Korte; B E Holmes; L Gooden; T Matheson; D J Feaster; J A Leff; L Wilson; L R Metsch; B R Schackman
Journal:  Eval Program Plann       Date:  2011-03-01

Review 6.  Meth/amphetamine use and associated HIV: Implications for global policy and public health.

Authors:  Louisa Degenhardt; Bradley Mathers; Mauro Guarinieri; Samiran Panda; Benjamin Phillips; Steffanie A Strathdee; Mark Tyndall; Lucas Wiessing; Alex Wodak; John Howard
Journal:  Int J Drug Policy       Date:  2010-02-01

7.  Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.

Authors:  Karina M Berg; Alain Litwin; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

8.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

9.  Comparing sexual risks and patterns of alcohol and drug use between injection drug users (IDUs) and non-IDUs who report sexual partnerships with IDUs in St. Petersburg, Russia.

Authors:  Nadia Abdala; Edward White; Olga V Toussova; Tatiana V Krasnoselskikh; Sergei Verevochkin; Andrei P Kozlov; Robert Heimer
Journal:  BMC Public Health       Date:  2010-11-05       Impact factor: 3.295

10.  Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004.

Authors:  Anna Grigoryan; H Irene Hall; Tonji Durant; Xiangming Wei
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

View more
  53 in total

1.  Criminal Justice System Involvement as a Risk Factor for Detectable Plasma HIV Viral Load in People Who Use Illicit Drugs: A Longitudinal Cohort Study.

Authors:  Sarah Ickowicz; N A Mohd Salleh; Nadia Fairbairn; Lindsey Richardson; Will Small; M-J Milloy
Journal:  AIDS Behav       Date:  2019-09

2.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

3.  Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment.

Authors:  Tania B Huedo-Medina; Roman Shrestha; Michael Copenhaver
Journal:  AIDS Behav       Date:  2016-08

4.  Clinic-Level Factors Associated With Time to Antiretroviral Initiation and Viral Suppression in a Large, Urban Cohort.

Authors:  Anne K Monroe; Lindsey P Happ; Nabil Rayeed; Yan Ma; Maria J Jaurretche; Arpi S Terzian; Kevin Trac; Michael A Horberg; Alan E Greenberg; Amanda D Castel
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

5.  Sleep disturbances in persons living with HIV.

Authors:  Diana M Taibi
Journal:  J Assoc Nurses AIDS Care       Date:  2013 Jan-Feb       Impact factor: 1.354

6.  HIV prevention, treatment, and care for people who inject drugs.

Authors:  Sarah Larney; Nickolas D Zaller; Josiah D Rich
Journal:  J Infect Dis       Date:  2013-04-16       Impact factor: 5.226

7.  Short term health-related quality of life improvement during opioid agonist treatment.

Authors:  B Nosyk; J W Bray; E Wittenberg; B Aden; A A Eggman; R D Weiss; J Potter; A Ang; Y-I Hser; W Ling; B R Schackman
Journal:  Drug Alcohol Depend       Date:  2015-10-25       Impact factor: 4.492

8.  A pilot study of sleep quality and rest-activity patterns in persons living with HIV.

Authors:  Diana M Taibi; Cynthia Price; Joachim Voss
Journal:  J Assoc Nurses AIDS Care       Date:  2012-10-10       Impact factor: 1.354

9.  Examining the efficacy of a computer facilitated HIV prevention tool in drug court.

Authors:  David S Festinger; Karen L Dugosh; Ann E Kurth; David S Metzger
Journal:  Drug Alcohol Depend       Date:  2016-02-27       Impact factor: 4.492

10.  A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.

Authors:  Roman Shrestha; Archana Krishnan; Frederick L Altice; Michael Copenhaver
Journal:  Contemp Clin Trials       Date:  2015-08-05       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.